SCOTCH PLAINS, N.J.--(BUSINESS WIRE)--April 28, 2006--Stem Cell Innovations, Inc. (OTCBB: SCLL - News) has filed a patent application protecting the differentiation of its proprietary human pluripotent stem cells (PCs) into neural progenitor cells and purified populations of motor neurons. These cells will initially be used in the Company's core drug discovery and toxicology platform. The Company is also exploring therapeutic applications of these cells.
